Evidence for efficacy is based on the results from the CHECKMATE-8HW study
Home World News FDA Approves Nivolumab with Ipilimumab for Unresectable or Metastatic MSI-H or dMMR...
Evidence for efficacy is based on the results from the CHECKMATE-8HW study
